(S)-1-(3-bromophenyl)-2,2,2-trifluoroethan-1-amine, 98%, 5g

(S)-tert-Butyl azetidine-2-carboxylate hydrochloride, 98%, 500mg

1-((2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 250mg

LIXIVAPTAN, 95%, 1mg

trans-beta-Methylstyrene (stabilized with TBC)>97.0%(GC)10mL

N,N,N',N'-Tetrakis(2-methoxyethyl)propanediamide, 95%, 100mg

1-(5-bromo-1-benzofuran-2-yl)ethanone, 97.0%, 5g

2,5-Dichloro-3-methylbenzoic acid, 1g

Cyclohexylphenylether, 99.48%, 5g

METHYL 3-METHYL-4-NITROISOXAZOLE-5-CARBOXYLATE, 95.0%, 5g

N-ALLYL-4-(2-CHLOROPHENYL)THIAZOL-2-AMINE, 90.0%, 2g

1-Heptyl-1H-1,2,3-benzotriazole, 98.0%, 250mg

TERT-BUTYL (1S,2R)-2-HYDROXYCYCLOPENTYLCARBAMATE, 95.0%, 5g